Allen Fields is responsible for Clinical, Regulatory and Technical Affairs, Drug Safety Pharmacovigilance, and Research and Development.
Allen has more than 28 years of experience as a clinical and regulatory affairs professional. He has managed IDEs, INDs, MAAs, NDAs, BLAs, ANDAs, SNDAs, 510Ks and PMAs. He has led drug development programs, due diligence, preparation of documents, strategic clinical and regulatory planning, and has had meetings with the global regulatory agencies. His expertise in drug development in all phases of development has led to over 35 approvals. He has held senior clinical and regulatory affairs positions at small and large pharmaceutical firms, including TAP Holdings, Purdue Pharma, Alliant Pharmaceuticals, and Quintiles International.
Allen holds a B.S. in Chemistry from Kansas Wesleyan University; M.Ed./M.S. work at Kansas State University; graduate work at University of Kansas School of Medicine; Neuropharmacology Fellowship; and currently additional graduate work at Johns Hopkins University and Walden University.